Vice President, Market Access

Posted 8 Days Ago
Be an Early Applicant
Boston, MA, USA
Hybrid
315K-400K Annually
Expert/Leader
Biotech • Pharmaceutical
The Role
The Vice President, Market Access will lead global market access strategy, focusing on payer strategy, pricing, reimbursement, and distribution for Verastem's oncology portfolio, ensuring optimal access and value realization.
Summary Generated by Built In

Role Overview

The Vice President, Market Access will lead the global market access strategy for Verastem Oncology’s portfolio, including the AVMAPKI + FAKZYNJA co-pack and pipeline assets. This role is accountable for payer strategy, pricing, reimbursement, trade & distribution, patient services, and government pricing, serving as the company’s senior “Voice of the Payer” across all key geographies. The VP will partner closely with Commercial, Medical, Regulatory, Clinical, Finance, and Legal teams to ensure optimal access and sustainable value realization. This role will report to the Chief Commercial Officer

Key Responsibilities

Strategy & Leadership

  • Develop, lead, and execute a comprehensive Global Value & Access Strategy aligned with Verastem’s scientific, clinical, and commercial objectives.
  • Serve as the senior “Voice of the Payer”, providing strategic guidance to executive leadership and cross‑functional teams on payer dynamics, access risks, and mitigation strategies.
  • Inform portfolio and lifecycle strategy through early payer input on clinical development, evidence generation, and value messaging.

Pricing, Reimbursement & Evidence

  • Design and execute pricing, reimbursement, and contracting strategies for AVMAPKI + FAKZYNJA co-pack and pipeline assets.
  • Provide clear recommendations on:
    • Life Cycle Management, Launch sequencing and pricing corridors
    • GPO and discretionary contracting to drive optimal value for Verastem Products
    • Reimbursement pathways (commercial, Medicare, Medicaid, ex‑US analogs)
    • HEOR, RWE, and other evidence requirements
  • Develop and maintain global and regional payer value propositions, ensuring local customization while maintaining strategic consistency.
  • Establish pricing governance and payer pricing guidance to enable launches within approved ranges and ensure long‑term sustainability.

Global & Regional Market Access

  • Build and maintain deep expertise in payer regulations, HTA processes, and access environments across major regions, including United States, EU, Japan, China, APAC, and MEA.
  • Lead regional adaptation of access strategy in partnership with local commercial and market access teams.
  • Anticipate future access challenges and evolving payer expectations, proactively identifying threats and opportunities.

Payer Engagement & External Affairs

  • Establish and maintain relationships with key payers, payer associations, and industry stakeholders.
  • Represent Verastem Oncology at key industry forums and conferences, including ASCO, SGO, AMCP, NCODA, COA, Asembia, and related access-focused meetings.
  • Support clinical pathway access and formulary inclusion for Verastem products.

Trade, Distribution & Patient Support

  • Oversee trade and distribution strategy, including contracting, specialty pharmacy relationships, data collection, and order‑to‑cash processes.
  • Ensure effective execution and continuous optimization of Verastem Cares, the company’s patient support and access program.
  • Partner with Compliance and Legal to ensure all trade and patient services activities meet regulatory and ethical standards.

Government Pricing & Compliance

  • Lead government pricing strategy and execution, including Medicaid, Medicare, 340B, and ex‑US price reporting as applicable.
  • Ensure accurate, compliant, and timely government price calculations, reporting, and audits.

Team & Matrix Leadership

  • Build, mentor, and lead a high‑performing market access organization.
  • Operate effectively in a matrixed environment, driving alignment across functions and regions.
  • Provide clear prioritization and decision‑making in a fast‑paced oncology growth environment.

Qualifications & Experience

  • Bachelor’s degree required; advanced degree (MBA, MPH, PharmD, PhD) strongly preferred.
  • 15+ years of progressive experience in market access, pricing, reimbursement, or payer strategy, with significant oncology experience.
  • Proven success leading US and global market access launches, ideally for rare disease and/or oncology products.
  • Deep knowledge of:
    • US payer landscape (commercial, Medicare, Medicaid)
    • Ex‑US HTA and pricing systems
    • Specialty pharmacy and oncology distribution models
  • Demonstrated executive presence with the ability to influence senior leadership and external stakeholders

The base salary range ($315,000 - $400,000) provided reflects our current estimate of what we anticipate paying for this position. Your actual base salary will be based on several factors, including job-related skills, experience, internal equity, relevant education or training, location, and market dynamics. In addition, you will be eligible for an annual bonus, equity compensation, and a competitive benefits package.

Skills Required

  • Bachelor's degree required; advanced degree strongly preferred
  • 15+ years of progressive experience in market access, pricing, reimbursement, or payer strategy
  • Significant oncology experience
  • Proven success leading US and global market access launches
  • Deep knowledge of US payer landscape
Am I A Good Fit?
beta
Get Personalized Job Insights.
Our AI-powered fit analysis compares your resume with a job listing so you know if your skills & experience align.

The Company
HQ: Needham, Massachusetts
128 Employees
Year Founded: 2010

What We Do

Verastem Oncology (Nasdaq: VSTM) (Verastem, Inc.) is a biopharmaceutical company committed to the development and commercialization of new medicines to improve the lives of patients diagnosed with RAS/MAPK pathway-driven cancers. Our pipeline is focused on novel small molecule drugs that inhibit critical signaling pathways in cancer that promote cancer cell survival and tumor growth, including RAF/MEK inhibition, FAK inhibition and KRAS G12D inhibition. Pursuing unexplored pathways demands that we’re purposeful in everything we do. And it’s an endeavor that’s only possible with an experienced team of employees and partners dedicated to a singular purpose: changing and improving the way cancer is treated by delivering novel therapies that address areas of high unmet need in RAS/MAPK pathway-driven cancers. At Verastem Oncology, it takes our diversity of backgrounds, expertise, perspectives, and skills to find the answers that patients need, but don’t have—yet. To join our team or for more information, please visit www.verastem.com. X/Twitter: @VerastemOncolog

Similar Jobs

In-Office or Remote
Waltham, MA, USA
341 Employees
292K-402K Annually

Cox Enterprises Logo Cox Enterprises

Search Engine Optimization Specialist

Artificial Intelligence • Automotive • Greentech • Information Technology • Machine Learning • Software • Cybersecurity
Remote or Hybrid
United States
50000 Employees
22-33 Hourly
Hybrid
Boston, MA, USA
130 Employees
150K-170K Annually
Hybrid
Boston, MA, USA
130 Employees
170K-200K Annually

Similar Companies Hiring

SOPHiA GENETICS Thumbnail
Software • Healthtech • Biotech • Big Data • Artificial Intelligence
Boston, MA
450 Employees
Pfizer Thumbnail
Artificial Intelligence • Healthtech • Machine Learning • Natural Language Processing • Biotech • Pharmaceutical
New York, NY
121990 Employees
Cencora Thumbnail
Healthtech • Logistics • Pharmaceutical
Conshohocken, PA
51000 Employees

Sign up now Access later

Create Free Account

Please log in or sign up to report this job.

Create Free Account